Form 4: Seer Director Terrance McGuire Details Future Equity Acquisition Under 10b5-1 Plan

Seer, Inc. Director Terrance McGuire has filed a Form 4 detailing the future acquisition of 20,500 Class A Common Stock Restricted Stock Units (RSUs) and 30,500 stock options, effective July 7, 2025, under a Rule 10b5-1 plan.

Summary

• Director Terrance McGuire acquired 20,500 shares of Class A Common Stock in the form of Restricted Stock Units (RSUs) at a price of $0 per share.
• McGuire also acquired stock options to purchase 30,500 shares of Class A Common Stock at an exercise price of $2.18 per share.
• Both the RSUs and stock options are scheduled to vest on the earlier of July 7, 2026, or the day prior to the Issuer's next annual meeting of stockholders.
• The stock options have an expiration date of July 7, 2035.
• Following these transactions, McGuire's direct beneficial ownership of Class A Common Stock will be 112,066 shares, plus 30,500 shares underlying the newly acquired options.
• Indirect beneficial ownership includes 210,982 shares held by Strong Bridge, LLC, and 78,947 shares held by Polaris Founders Capital Fund I, L.P.
• The transactions were made pursuant to a Rule 10b5-1(c) plan, indicating a pre-arranged trading strategy.

Sentiment

Score: 7

Explanation: The filing indicates a director's acquisition of additional equity, including RSUs and stock options, which generally signals confidence in the company's future prospects and aligns management interests with shareholder value. This is a standard compensation mechanism.

Positives

• Director Terrance McGuire's acquisition of additional equity (RSUs and stock options) aligns his interests with those of shareholders, indicating confidence in Seer, Inc.'s future performance.
• The transactions are part of a pre-arranged Rule 10b5-1 plan, which demonstrates a structured approach to equity compensation and insider trading compliance.

Risks

• The value of the acquired RSUs and stock options is subject to the future performance of Seer, Inc.'s stock price.
• The vesting of RSUs and options is contingent on future dates or events (next annual meeting), meaning the shares are not immediately available for sale or full ownership.

Future Outlook

The filing indicates future equity grants to a director, aligning management incentives with long-term shareholder value through vesting schedules tied to future dates or the next annual meeting.

Management Comments

• The reported shares are represented by restricted stock units, or RSUs, which vest on the earlier of (i) July 7, 2026 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders.
• Shares subject to the option vest on the earlier of (i) July 7, 2026 or (ii) the day prior to the date of the Issuer's next annual meeting of stockholders.
• Each of PFCM, Flint, and the Reporting Person disclaims beneficial ownership of securities held by PFCF I, and this report shall not be deemed an admission that the Reporting Person, Flint, or PFCM is the beneficial owner of these securities for purposes of Section 16 or for any other purpose, except to the extent of their respective pecuniary interests therein.

Industry Context

This Form 4 filing is a standard disclosure for insider transactions, common across all publicly traded companies. It reflects a typical mechanism for executive and director compensation in the biotechnology or life sciences tools industry, where long-term incentives like RSUs and stock options are used to retain talent and align interests with company growth.

Comparison to Industry Standards

• The use of Restricted Stock Units (RSUs) and stock options as part of director compensation is a common practice across the U.S. public market, including companies comparable to Seer, Inc. in the life sciences tools sector.
• For instance, companies like Illumina (ILMN) or Pacific Biosciences of California (PACB) frequently utilize similar equity-based compensation structures to incentivize directors and executives.
• The vesting schedule tied to future dates or the next annual meeting is also standard for such grants, ensuring long-term commitment.
• The exercise price of $2.18 for the options would typically be compared to Seer's stock price on the grant date to assess if they are 'in-the-money' or 'out-of-the-money' at the time of grant, though the document does not provide the stock price on the transaction date.

Related Party Transactions

• Indirect beneficial ownership through Strong Bridge, LLC, for which the Reporting Person serves as an operating manager.
• Indirect beneficial ownership through Polaris Founders Capital Fund I, L.P., where the Reporting Person is a managing member of the general partner (Polaris Founders Capital Management Co. I, L.L.C.).

Stakeholder Impact

• Shareholders: The acquisition of equity by a director can be viewed positively as it aligns management's financial interests with shareholder returns.

Next Steps

• Vesting of RSUs and stock options on or after July 7, 2026, or the day prior to the Issuer's next annual meeting of stockholders.
• Potential exercise of stock options by Terrance McGuire before July 7, 2035.

Key Dates

Recommendation

Keywords

Seer Inc., SEER, Form 4, Terrance McGuire, Director, Insider Trading, Equity Compensation, Restricted Stock Units, RSUs, Stock Options, Beneficial Ownership, Rule 10b5-1, SEC Filing